Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (DOCMF)
OTHER OTC:DOCMF
DOCMF Stock Chart & Stats
$0.88
--
Market closed
$0.88
--
Day’s Range― - ―
52-Week Range$0.62 - $1.36
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
£847.78M
Enterprise Value$939.35M
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£397.10M
Price to Earnings (P/E)―
Beta1.57
Next Earnings
May 28, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend Yield3.32%
Share Statistics
EPS (TTM)-0.01
Shares Outstanding967,343,750
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.34
Price to Sales (P/S)0.62
P/FCF Ratio2.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£1.25Price Target Upside42.44% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£10.41M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationSustained and improving free cash flow provides durable financial flexibility: it funds capex, DTC store and e-commerce investment, and working capital without relying on new debt. That underpins the firm's ability to execute strategy and absorb cyclical retail volatility over 2–6 months.
Net Debt Reduction / Manageable LeverageMaterial year-on-year debt reduction and a modest net debt-to-EBITDA multiple improve financial resilience. Lower leverage reduces refinancing and interest risk, enabling the company to weather slower sales periods and invest in product and channel initiatives without compromising liquidity.
High Gross Margins & Improved Revenue QualityA high gross margin and a shift toward full-price DTC sales signal durable pricing power and improved revenue quality. Higher mix of full-price DTC reduces reliance on markdowns, supporting margin sustainability and long-term brand strength across channels and regions.
Bears Say
Declining Revenue And Net ProfitabilityPersistent top-line decline and a near-zero net margin materially constrain reinvestment capacity and shareholder returns. If revenue contraction continues, it risks underutilized retail capacity, pressure on wholesale relationships, and makes margin recovery harder despite strong gross margins.
Severe Fall In Return On EquityA collapse in ROE indicates the company is generating far less profit from shareholder capital, reflecting margin compression and lower asset efficiency. Sustained low ROE reduces attractiveness for capital allocation and raises the bar for management to restore profitable growth.
Regional And Product Headwinds, Tariff CostsConcentrated EMEA DTC weakness, persistent product-segment issues, and tariff exposure create structural topline and cost pressures. These factors can weigh on sustainable growth and margins across planning horizons unless product/market mix and supply responses are implemented effectively.
Dr. Martens Plc News
DOCMF FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest stock price was $0.62 and its highest was $1.36 in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £847.78M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is May 28, 2026 which is in 79 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 20, 2025. The company reported -$0.012 earnings per share for the quarter, the consensus estimate of -$0.012 by $0.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of $0.011 which represents an annual dividend yield of 3.32%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is 0.06.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 967,343,750 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of -$0.012 in its last earnings report, expectations of -$0.012. Following the earnings report the stock price went down -11.163%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in DOCMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£1.25 (42.44% Upside)
£1.25 (42.44% Upside)
Insider Transactions
Bought Shares
Worth £80.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.57%
12-Months-Change
Fundamentals
Return on Equity
4.61%
Trailing 12-Months
Asset Growth
-7.19%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
DOCMF Stock 12 Month Forecast
Average Price Target
$1.25
▲(42.44% Upside)